Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719237 · ClinicalTrials.gov registry record · Phase 4
Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture
A Phase 4 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01719237 is a Phase 4 study that has completed, run by University of New Mexico. The registered enrollment target is 60 participants.
The verdict
NCT01719237, a Phase 4 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
A double blinded randomized controlled trial comparing the onset and duration of the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using a long acting local anesthestic (Ropivacaine) with a mixture of a long and short acting local anesthestic (Ropivacaine-Chloroprocaine Mixture).
Interventions
- DRUG Ropivacine and Chloroprocaine mixture
- DRUG Ropivacaine only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01719237
The ClinicalTrials.gov registry entry for NCT01719237 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacine and Chloroprocaine mixture is the first listed.
NCT01719237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01719237 about?
NCT01719237 is a clinical study titled "Trial Comparing the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using Ropivacaine Versus Ropivacaine-Chloroprocaine Mixture". A double blinded randomized controlled trial comparing the onset and duration of the Onset and Duration of Ultrasound Guided Supraclavicular Nerve Blocks Using a long acting local anesthestic (Ropivacaine) with a mixture of a long and short acting local anesthestic (Ropivacaine-Chloroprocaine Mixtur...
What is the current status of trial NCT01719237?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2009-08. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01719237?
The interventions under investigation include: Ropivacine and Chloroprocaine mixture (DRUG), Ropivacaine only (DRUG).
Who is sponsoring clinical trial NCT01719237?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.